GLP-1 medications currently available through our pharmacy include: We currently carry two GLP-1 options for patients managing type 2 diabetes: Victoza (Liraglutide Injection) Victoza is a once-daily injection that was the first GLP-1 approved for cardiovascular risk reduction (LEADER trial, 2016)
Our team will ask a few questions and help you choose or mix based on what your body needs right now
Read more obesity medicine news at Obesity.News All links: linktr.ee/manonthemounjaro #GLP1 #Medicare #Zepbound #Wegovy #Obesity #WeightLoss #ObesityMedicine #MedicareBridgeProgram #Tirzepatide #Semaglutide #Foundayo #Orforglipron #Prediabetes #Type2Diabetes #WeightManagement #AngelaFitch #OnThePen #MedicareCoverage #GLP1News #ObesityTreatment #HealthcarePolicy #WeightLossMedication #ChronicDisease #Mounjaro #Retatrutide #Lilly #NovoNordisk #ObesityAdvocacy #GLP1Community #MedicarePatients What Comes After Zepbound
and The approval of drugs under new drug applications or abbreviated drug applications
While many weight loss drugs have severe side effects or are scams that don't work and prey upon people with insecurities, recent medical advancements have led to the development of GLP-1 receptor agonists, commonly known as GLPs
The goal is to avoid significant appetite suppression, which could lead to underfueling and negatively affect performance and recovery